AVIR — Atea Pharmaceuticals, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2020-10-30.
Performance
Technicals
Others in Healthcare
Measured signals that fired on AVIR
| date | signal | measured base rate |
|---|---|---|
| 2026-03-06 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-18 | DUNCAN BARBARA GAYLE Director | Option exercise | 29.6K | 0.00 | 0 |
| 2026-06-18 | Adams Jerome M. Director | Option exercise | 29.6K | 0.00 | 0 |
| 2026-06-18 | Murphy Polly A. Director | Option exercise | 29.6K | 0.00 | 0 |
| 2026-06-18 | BERGER FRANKLIN M Director | Option exercise | 29.6K | 0.00 | 0 |
| 2026-06-18 | Lucidi Bruno Director | Option exercise | 29.6K | 0.00 | 0 |
| 2026-06-18 | Polsky Bruce Director | Option exercise | 29.6K | 0.00 | 0 |
| 2026-05-18 | Murphy Polly A. Director | Open-market purchase | 6.1K | 4.17 | 25.4K |
| 2026-03-11 | Corcoran Andrea See Remarks | Option exercise | 60.0K | 1.24 | 74.4K |
| 2026-02-03 | Sommadossi Jean-Pierre President, CEO, and Chairman | Option exercise | 300.0K | 1.24 | 372.0K |
| 2026-01-31 | Sommadossi Jean-Pierre President, CEO, and Chairman | Shares withheld for tax | 106.1K | 4.24 | 449.8K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| FMR LLC | 64.3M | 12.0M |
| BlackRock, Inc. | 45.4M | 8.4M |
| BML Capital Management, LLC | 38.0M | 7.1M |
| TANG CAPITAL MANAGEMENT LLC | 25.9M | 4.8M |
| VANGUARD CAPITAL MANAGEMENT LLC | 17.5M | 3.2M |
| Bain Capital Life Sciences Investors, LLC | 12.7M | 2.4M |
| TWO SIGMA INVESTMENTS, LP | 10.0M | 1.9M |
| GEODE CAPITAL MANAGEMENT, LLC | 9.4M | 1.7M |
| STATE STREET CORP | 9.1M | 1.7M |
| DIMENSIONAL FUND ADVISORS LP | 6.8M | 1.3M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Atea Pharmaceuticals, Inc. (AVIR) filed form 8-K · 2026-08-12 · SEC EDGAR
Ask the AI about AVIR
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →